Open AccessSuccessful treatment of psychosis in dentatorubral‐pallidoluysian atrophy with quetiapine: A case report
Author(s) -
Narita Zui,
Sumiyoshi Tomiki
Publication year - 2018
Publication title -
neuropsychopharmacology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.661
H-Index - 13
ISSN - 2574-173X
DOI - 10.1002/npr2.12005
Subject(s) - quetiapine , psychosis , quetiapine fumarate , antipsychotic , medicine , adverse effect , atypical antipsychotic , psychiatry , atrophy , schizophrenia (object oriented programming) , pediatrics , psychology
Patients with dentatorubral‐pallidoluysian atrophy ( DRPLA ) sometimes elicit psychosis. First‐generation antipsychotic drugs have been reported to be effective in treating psychotic symptoms associated with the disease. However, little information is available on the benefits of second‐generation antipsychotic drugs ( SGA s). Case We report on a 47‐year‐old man with DRPLA whose psychotic symptoms were effectively treated with quetiapine, one of the SGA s. He suffered from delusions, auditory hallucinations, and disorganized speech. Initially, other antipsychotic drugs were tried, but were withdrawn because of adverse effects before switching to quetiapine. Conclusion Our observations add to the notion that some of the SGA s are useful for ameliorating psychosis in DRPLA .